CPHI [CHINA PHARMAS,] 10-K/A: o x o x x o x Large

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-K/A, Date: 2009-06-24
Original SEC Filing: Click here


Webplus: CPHI/20090624/10-K.A_1/1/000.htm SEC Original: cph10ka123108.htm
o x o x x o x Large accelerated filer o Accelerated filer o Non-accelerated filer o




Webplus: CPHI/20090624/10-K.A_1/2_EX-10.7/000.htm SEC Original: cph10kaex107123108.htm
January 11, 2008 1) A retainer of RMB 40,000 per year, payable quarterly within 5 days of the start of the quarter. If you agree to the terms and conditions stated above, please sign and date this letter below. Chairman of the Board EX-10.7 2 cph10kaex107123108.htm




Webplus: CPHI/20090624/10-K.A_1/3_EX-10.8/000.htm SEC Original: cph10kaex108123108.htm
January 11, 2008 1) A retainer of RMB 40,000 per year, payable quarterly within 5 days of the start of the quarter. If you agree to the terms and conditions stated above, please sign and date this letter below. Chairman of the Board EX-10.8 3 cph10kaex108123108.htm




Webplus: CPHI/20090624/10-K.A_1/4_EX-31.1/000.htm SEC Original: cph10kaex311123108.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with




Webplus: CPHI/20090624/10-K.A_1/5_EX-31.2/000.htm SEC Original: cph10kaex312123108.htm
CERTIFICATION OF CHIEF FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Frank Waung, certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with




Webplus: CPHI/20090624/10-K.A_1/6_EX-32.1/000.htm SEC Original: cph10kaex321123108.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Zhilin Li Chief Executive Officer EX-32.1 6 cph10kaex321123108.htm




Webplus: CPHI/20090624/10-K.A_1/7_EX-32.2/000.htm SEC Original: cph10kaex322123108.htm
CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Frank Waung Chief Financial Officer EX-32.2 7 cph10kaex322123108.htm



Company Information:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-K/A, Date: 2009-06-24CIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216

Home Page Forums

By | 2016-03-03T22:21:06+00:00 June 24th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar